Chyong-Huey Lai

31PUBLICATIONS
109CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Pacific Peoples medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Aug 22, 2026
E-cadherin-driven interleukin-6 expression promotes autophagy-mediated platinum resistance in ovarian clear cell carcinoma.

|Jan 23, 2026
Combined targeting poly (ADP-ribose) polymerase and receptor tyrosine kinase inhibits ovarian clear cell carcinoma progression through disrupted ribosome biogenesis.

Chiao-Yun Lin, An-Shine Chao, Angel Chao

|Oct 09, 2025
Distinct genomic subgroups and mutational patterns in undifferentiated/dedifferentiated endometrial carcinoma.

Chen-Yang Huang, Angel Chao, Chiao-Yun Lin

|Jul 22, 2025
Metastatic Cervical Cancer in the Asia-Pacific Region: Current Treatment Landscape and Barriers.

Jeffrey Chee-Hong Goh, Chyong-Huey Lai, Efren Javier Domingo

|Jul 01, 2025
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial.

Kenichi Harano, Roldano Fossati, Beatriz Pardo

|Nov 15, 2024
Molecular profiling reveals novel therapeutic targets and clonal evolution in ovarian clear cell carcinoma.

Angel Chao, Chen-Yang Huang, Willie Yu

Pageof 6

Frequent Collaborators

10 joint publications

Ren-Chin Wu

8 joint publications

Angel Chao

7 joint publications

Lan-Yan Yang

7 joint publications

Chiao-Yun Lin